Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.
De Luca G, Gibson M, Cutlip D, Huber K, Dudek D, Bellandi F, Noc M, Maioli M, Zorman S, Zeymer U, Secco GG, Mesquita Gabriel H, Emre A, Arntz HR, Rakowski T, Gyongyosi M, Hof AW; EGYPT Cooperation. De Luca G, et al. Among authors: bellandi f. Arch Cardiovasc Dis. 2013 Mar;106(3):155-61. doi: 10.1016/j.acvd.2012.12.007. Epub 2013 Apr 2. Arch Cardiovasc Dis. 2013. PMID: 23582677 Free article.
Usefulness of dobutamine Tc-99m sestamibi-gated single-photon emission computed tomography for prediction of left ventricular ejection fraction outcome after coronary revascularization for ischemic cardiomyopathy.
Leoncini M, Sciagrà R, Maioli M, Bellandi F, Marcucci G, Sestini S, Chiocchini S, Dabizzi RP. Leoncini M, et al. Among authors: bellandi f. Am J Cardiol. 2002 Apr 1;89(7):817-21. doi: 10.1016/s0002-9149(02)02203-8. Am J Cardiol. 2002. PMID: 11909565
Use of 99mTc-sestamibi gated SPECT to assess the influence of anterograde flow before primary coronary angioplasty on tissue salvage and functional recovery in acute myocardial infarction.
Leoncini M, Bellandi F, Sciagrà R, Maioli M, Toso A, Sestini S, Coppola A, Mennuti A, Dabizzi RP, Pupi A. Leoncini M, et al. Among authors: bellandi f. Eur J Nucl Med Mol Imaging. 2004 Oct;31(10):1378-85. doi: 10.1007/s00259-004-1595-9. Epub 2004 Jun 19. Eur J Nucl Med Mol Imaging. 2004. PMID: 15221297 Clinical Trial.
Therapeutic strategies, immediate and mid-term outcomes in non-ST-segment elevation acute coronary syndromes with respect to age: a single-center registry of 488 consecutive patients.
Leoncini M, Maioli M, Bellandi F, Galvani M, Ottani F, Toso A, Di Vincenzo E, Gallopin M, Dabizzi RP. Leoncini M, et al. Among authors: bellandi f. Clin Cardiol. 2004 Aug;27(8):475-9. doi: 10.1002/clc.4960270811. Clin Cardiol. 2004. PMID: 15346846 Free PMC article. Review.
Effects of tirofiban plus clopidogrel versus clopidogrel plus provisional abciximab on biomarkers of myocardial necrosis in patients with non-ST-elevation acute coronary syndromes treated with early aggressive approach. Results of the CLOpidogrel, upstream TIrofiban, in cath Lab Downstream Abciximab (CLOTILDA) study.
Leoncini M, Toso A, Maioli M, Bellandi F, Badia T, Politi A, De Servi S, Dabizzi RP. Leoncini M, et al. Among authors: bellandi f. Am Heart J. 2005 Sep;150(3):401. doi: 10.1016/j.ahj.2005.06.006. Am Heart J. 2005. PMID: 16169315 Clinical Trial.
84 results